Brokerages predict that Nextgen Healthcare Inc (NASDAQ:NXGN) will post earnings of $0.21 per share for the current quarter, Zacks Investment Research reports. Ten analysts have issued estimates for Nextgen Healthcare’s earnings. Nextgen Healthcare posted earnings of $0.16 per share during the same quarter last year, which suggests a positive year over year growth rate of 31.3%. The firm is scheduled to announce its next quarterly earnings report after the market closes on Thursday, May 23rd.
According to Zacks, analysts expect that Nextgen Healthcare will report full-year earnings of $0.84 per share for the current financial year. For the next fiscal year, analysts anticipate that the business will report earnings of $0.90 per share. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Nextgen Healthcare.
Several research firms recently weighed in on NXGN. Zacks Investment Research upgraded shares of Nextgen Healthcare from a “hold” rating to a “buy” rating and set a $21.00 target price on the stock in a report on Friday, April 26th. Svb Leerink upgraded shares of Nextgen Healthcare from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $22.00 in a report on Thursday, April 25th. Finally, Leerink Swann upgraded shares of Nextgen Healthcare from a “market perform” rating to an “outperform” rating in a report on Thursday, April 25th. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $19.50.
Shares of NASDAQ:NXGN traded up $0.23 during midday trading on Wednesday, hitting $19.35. 212,223 shares of the company’s stock traded hands, compared to its average volume of 208,792. The company has a current ratio of 1.32, a quick ratio of 1.31 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $1.25 billion, a price-to-earnings ratio of 33.95, a PEG ratio of 3.21 and a beta of 1.18. Nextgen Healthcare has a twelve month low of $13.89 and a twelve month high of $23.73.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Read More: Is it Safe to Invest in Commodities?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.